A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.

Ivana StružinskáNikola HájkováJan HojnýEva KrkavcováRomana MichálkováJiří DvořákKristýna NěmejcováRadoslav MatějJan LacoJana DrozenováPavel FabianJitka HausnerováGábor MéhesPetr ŠkapaMarián ŠvajdlerDavid CibulaFilip FrühaufMichaela Kendall BártůPavel Dundr

Published in: Diagnostic pathology (2023)

and MSI-High OCCC. Moreover, the molecular landscape of OCCC revealed several potential therapeutical targets. Molecular testing can provide the potential for targeted therapy in patients with recurrent or metastatic tumors.

Keyphrases

clear cell
squamous cell carcinoma
single cell
small cell lung cancer
high grade
human health
gene expression
risk assessment